secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0001558370-21-009299
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics appoints Karimah Es Sabar to Board of Directors
---------------------------------------------------------------------

- Karimah Es Sabar appointed to Capricor's Board of Directors effective July 23, 2021.
- She brings over 35 years of biopharma leadership, drug development, and venture investing experience.
- Es Sabar currently serves as CEO and Partner at Quark Venture LP.
- She will receive standard non-employee director compensation under Company policies.
- Previously held senior roles at CDRD and Sanofi Pasteur; holds degrees in neurochemistry and biochemistry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/0001558370-21-009299-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/tmb-20210723x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-009299

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer